Since tauopathy underlies a verity of neurodegenerative conditions, our current findings may pave the path for treatment by peptide drugs that have an impact on tubulin-Tau interaction and specific neurofibrillary tangle populations [51]. This evidence concerns the gene MAPT and tauopathy.